FI960660A0 - Parannuksia platinakomplekseihin - Google Patents

Parannuksia platinakomplekseihin

Info

Publication number
FI960660A0
FI960660A0 FI960660A FI960660A FI960660A0 FI 960660 A0 FI960660 A0 FI 960660A0 FI 960660 A FI960660 A FI 960660A FI 960660 A FI960660 A FI 960660A FI 960660 A0 FI960660 A0 FI 960660A0
Authority
FI
Finland
Prior art keywords
carboxylate
hydroxy
platinum complexes
different
halo
Prior art date
Application number
FI960660A
Other languages
English (en)
Swedish (sv)
Other versions
FI960660A (fi
FI120493B (fi
Inventor
Barry Anthony Murrer
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of FI960660A0 publication Critical patent/FI960660A0/fi
Publication of FI960660A publication Critical patent/FI960660A/fi
Application granted granted Critical
Publication of FI120493B publication Critical patent/FI120493B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
FI960660A 1995-02-14 1996-02-14 Parannuksia platinakomplekseihin FI120493B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9502799 1995-02-14
GBGB9502799.1A GB9502799D0 (en) 1995-02-14 1995-02-14 Improvements in platinum complexes

Publications (3)

Publication Number Publication Date
FI960660A0 true FI960660A0 (fi) 1996-02-14
FI960660A FI960660A (fi) 1996-08-15
FI120493B FI120493B (fi) 2009-11-13

Family

ID=10769529

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960660A FI120493B (fi) 1995-02-14 1996-02-14 Parannuksia platinakomplekseihin

Country Status (19)

Country Link
US (2) US5665771A (fi)
EP (1) EP0727430B1 (fi)
JP (1) JP3219235B2 (fi)
KR (1) KR100339866B1 (fi)
AT (1) ATE202111T1 (fi)
AU (1) AU707814B2 (fi)
CA (1) CA2169019C (fi)
DE (1) DE69613254T2 (fi)
DK (1) DK0727430T3 (fi)
ES (1) ES2157399T3 (fi)
FI (1) FI120493B (fi)
GB (1) GB9502799D0 (fi)
GR (1) GR3036513T3 (fi)
HK (1) HK1011997A1 (fi)
NO (1) NO307569B1 (fi)
NZ (1) NZ280946A (fi)
PT (1) PT727430E (fi)
TW (1) TW432068B (fi)
ZA (1) ZA96885B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001872A (en) * 1999-03-05 1999-12-14 Virginia Commonwealth University Water soluble transplatinum complexes with anti-cancer activity and method of using same
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
PL202731B1 (pl) * 1999-04-13 2009-07-31 Anormed Sposób wytwarzania kompleksu cis-platynowego oraz kompleks cis-platynowy
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6894049B1 (en) * 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
JP2005501859A (ja) 2001-08-23 2005-01-20 イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム 白金錯体及びガンの処置におけるそれらの使用
WO2007021852A2 (en) * 2005-08-11 2007-02-22 Virginia Commonwealth University Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents
US8173686B2 (en) * 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
MX2009008488A (es) * 2007-02-09 2010-01-15 Poniard Pharmaceuticals Inc Forma estabilizadora de dosificacion oral de picoplatino.
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
JP2010518088A (ja) * 2007-02-09 2010-05-27 ポニアード ファーマシューティカルズ， インコーポレイテッド カプセル化されたピコプラチン
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
EP2178893A4 (en) * 2007-07-16 2012-09-19 Poniard Pharmaceuticals Inc ORAL FORMULATIONS FOR PICOPLATIN
CA2715353A1 (en) * 2008-02-08 2009-08-13 Poniard Pharmaceuticals, Inc. Use of picoplatin and cetuximab to treat colorectal cancer
CN101775040B (zh) * 2009-12-31 2012-05-09 南京臣功制药有限公司 吡铂的制备方法
WO2015009841A2 (en) 2013-07-16 2015-01-22 Blend Therapeutics Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof
CN106943343B (zh) * 2016-01-06 2020-05-12 山东新时代药业有限公司 一种甲啶铂注射液及其制备方法
WO2017192290A1 (en) 2016-05-04 2017-11-09 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
KR840007599A (ko) * 1983-01-21 1984-12-08 마쓰바라 이찌로오 백금 착화합 유기물의 제조방법
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
ATE63919T1 (de) * 1984-06-27 1991-06-15 Johnson Matthey Plc Platinkoordinationsverbindungen.
JPS61238795A (ja) * 1985-04-16 1986-10-24 エンゲルハード・コーポレーシヨン 白金トリアミン抗腫瘍剤
CA1327039C (en) * 1986-12-18 1994-02-15 Tetsushi Totani Ammine-alicyclic amine-platinum complexes and antitumor agents
US4812193A (en) * 1986-12-22 1989-03-14 Gauron Richard F Inset panel fastener and method of using
DE68918878T2 (de) * 1988-02-02 1995-02-23 Johnson Matthey Inc Pt(IV) Komplexe.
GB8806044D0 (en) * 1988-03-14 1988-04-13 Johnson Matthey Plc Platinum coordination compounds
GB9105037D0 (en) * 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
US5624919A (en) * 1993-09-14 1997-04-29 The University Of Vermont And State Agricultural College Trans platinum (IV) complexes
GB9408218D0 (en) * 1994-04-26 1994-06-15 Johnson Matthey Plc Improvements in platinum complexes
PL202731B1 (pl) * 1999-04-13 2009-07-31 Anormed Sposób wytwarzania kompleksu cis-platynowego oraz kompleks cis-platynowy
JP2005501859A (ja) * 2001-08-23 2005-01-20 イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム 白金錯体及びガンの処置におけるそれらの使用
AU2005278924A1 (en) * 2004-09-01 2006-03-09 Platco Technologies (Proprietary) Limited Preparation of platinum(II) complexes
WO2007021852A2 (en) * 2005-08-11 2007-02-22 Virginia Commonwealth University Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents

Also Published As

Publication number Publication date
PT727430E (pt) 2001-11-30
EP0727430B1 (en) 2001-06-13
ATE202111T1 (de) 2001-06-15
EP0727430A1 (en) 1996-08-21
JP3219235B2 (ja) 2001-10-15
GR3036513T3 (en) 2001-12-31
AU707814B2 (en) 1999-07-22
KR960030940A (ko) 1996-09-17
ES2157399T3 (es) 2001-08-16
NO960569D0 (no) 1996-02-13
NO307569B1 (no) 2000-04-25
CA2169019C (en) 2003-02-04
US5665771A (en) 1997-09-09
ZA96885B (en) 1996-08-14
FI960660A (fi) 1996-08-15
HK1011997A1 (en) 1999-07-23
CA2169019A1 (en) 1996-08-15
JPH08259581A (ja) 1996-10-08
NO960569L (no) 1996-08-15
FI120493B (fi) 2009-11-13
DK0727430T3 (da) 2001-09-03
GB9502799D0 (en) 1995-04-05
TW432068B (en) 2001-05-01
AU4225896A (en) 1996-08-22
DE69613254T2 (de) 2001-09-20
USRE41209E1 (en) 2010-04-06
KR100339866B1 (ko) 2002-11-07
NZ280946A (en) 1997-05-26
DE69613254D1 (de) 2001-07-19

Similar Documents

Publication Publication Date Title
FI960660A0 (fi) Parannuksia platinakomplekseihin
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
ATE205216T1 (de) Platinkomplexe
YU48701A (sh) Fenilfenantridini sa dejstvom inhibicije pde-iv
EP1068357A4 (en) THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BASED ON THE ROLE OF THE CXCR-4 GENE IN ONCOGENESIS
ES8701707A1 (es) Procedimiento para preparar derivados del acido acrilico conactividad fungicida
DE69629670D1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
DK0952148T3 (da) Cyclobutylaryloxyarylsulfonylaminohydroxamsyrederivater
DE69012601T2 (de) Gentherapie durch stützgewebebezügliche Zellen.
FR2578988B1 (fr) Procede de regulation de la concentration de solutions de desinfection notamment oxydantes contenant des molecules desinfectantes
DE69533043D1 (de) Acrylamid-derivate und verfahren zu deren herstellung
DE69704716D1 (de) Zusammensetzung und deren verwendung
DE3678086D1 (de) Rhizoxinderivate, ihre herstellung und pharmazeutische verwendung.
DE69729114D1 (de) 1,3-diphenylphosphinopropan-liganden und entsprechende übergangsmetallkomplexe, deren herstellung und verwendung
DE68901024D1 (de) Gegen anaerobe bakterien wirksame antibiotika, ihre produktion und enterobakter-staemme, die sie produzieren.
TR199701744T1 (xx) Ha�arat m�cadele maddesi olarak s�bstit�e edilmi� 1,3-Dioksan-5-�lamino-Heterosayk�llar�.
DE69415700T2 (de) Strahlungsenergievorrichtung für die mikroklimatische Regulierung von isolierten Umgebungen bestimmt für Aquikultur, Hydrokultur und Gewächshauskultur
TH19367A (th) ซับสทิทิวเทค 2-เฟนิล พิริดีน
TH29868A (th) วิธีการและองค์ประกอบของสารสำหรับทำให้สีของผิวหนังจางลง
TR200100476T2 (tr) N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları.
DE60025821D1 (de) Any-rf gen, wachstumsrühe regulierende substanz, verfahren zu seiner herstellungund zellregulator fur lebende zellen

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ANORMED INC.

FG Patent granted

Ref document number: 120493

Country of ref document: FI

MA Patent expired